Richard S Geary
CIK 1442730 · EVP, Chief Development Officer · last filed 2025-11-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.15M
Companies
2
Total Filings
112
Lifetime Open-Market Net
-$31.73M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IONS | EVP, Chief Development Officer | 77,957 | $53.28 | $4.15M | -$23.74M | 60 | 2025-11-07 |
| IONIS PHARMACEUTICALS INC (ISIS) Delisted | SVP, Development | 4,820 | — | — | -$7.99M | 38 | 2015-07-02 |
Recent Filings · Page 11 of 12
112 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-01-03 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | +1,625 | $10.0K | EDGAR |
| 2011-12-22 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$1.3K | EDGAR |
| 2011-12-20 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$4.0K | EDGAR |
| 2011-07-01 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Other (J) | +265 | $2.1K | EDGAR |
| 2011-01-03 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | +2,434 | $19.0K | EDGAR |
| 2010-12-29 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$4.0K | EDGAR |
| 2010-12-28 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$180 | EDGAR |
| 2010-12-27 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$2.7K | EDGAR |
| 2010-01-05 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | +1,579 | $14.9K | EDGAR |
| 2009-07-02 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$1.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.